Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Passive smoking, platelet function and atherosclerosis

H Kritz1, H Sinzinger

  • 1Wilhelm-Auerswald Atherosclerosis Research Group, Vienna.

Wiener Klinische Wochenschrift
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Imaging of early carotid artery atherosclerotic lesions with 111In-labeled polyelonalhuman IgG (HIG)].

Nuklearmedizin. Nuclear medicine·2006
Same author

Endothelial dysfunction, atherosclerosis and diabetes.

Acta medica Austriaca·2001
Same author

6-oxo-PGF(1 alpha)and 8-epi-PGF(2 alpha)in the arterial wall layers of various species: a comparison between intact and atherosclerotic areas.

Prostaglandins, leukotrienes, and essential fatty acids·2001
Same author

[HDL-2000: A consensus. HDL--a neglected lipoprotein].

Wiener klinische Wochenschrift·2001
Same author

Association of lipoprotein(a), prostaglandin I(2)--synthesis stimulating plasma factor, biological half-life of prostaglandin I(2)and high-density lipoproteins in HIV-1 infection of different stages.

Prostaglandins, leukotrienes, and essential fatty acids·2000
Same author

[Unaltered homocysteine levels during simvastatin therapy].

Wiener klinische Wochenschrift·2000
Same journal

[Vaccination of immunocompromised individuals: Expert opinion - update 2026].

Wiener klinische Wochenschrift·2026
Same journal

Systematic review of clinical evidence for Kneipp medicine.

Wiener klinische Wochenschrift·2026
Same journal

Pelvic resections in primary sarcomas : Surgical outcomes and survival analysis of 75 patients.

Wiener klinische Wochenschrift·2026
Same journal

Jungmediziner*innen am Start: 11. Workshop für den medizinischen Nachwuchs.

Wiener klinische Wochenschrift·2026
Same journal

Stellungnahme der ÖGP zur geplanten Gesetzesnovelle zum Nichtraucherschutzgesetz.

Wiener klinische Wochenschrift·2026
Same journal

MUW researcher of the month: Dr. Moritz Schaefer.

Wiener klinische Wochenschrift·2026
See all related articles

Passive smoking, like active smoking, poses health risks by affecting blood clotting. Research indicates that platelet activation plays a key role in the harmful vascular effects of passive smoke exposure.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Toxicology

Background:

  • Active smoking is a recognized risk factor for atherosclerosis, coronary heart disease, and peripheral vascular disease.
  • Smoking's impact on platelet function, the eicosanoid system, and thromboxane A2 generation contributes to hemostatic imbalance.
  • The health risks of passive smoking are increasingly discussed, but data on its effects on hemostasis remain limited.

Purpose of the Study:

  • To investigate the role of passive smoking on hemostatic parameters.
  • To explore the involvement of platelet activation in the vascular effects of passive smoking.

Main Methods:

  • Review of existing literature on smoking and hemostasis.
  • Analysis of studies examining passive smoking's impact on platelet function and vascular health.

Related Experiment Videos

Main Results:

  • Limited data exists on passive smoking's specific effects on hemostatic parameters.
  • Evidence suggests significant involvement of platelet activation in the adverse vascular effects of passive smoking.

Conclusions:

  • Passive smoking may contribute to hemostatic imbalance and vascular damage.
  • Platelet activation is a likely mechanism underlying the negative vascular consequences of passive smoking exposure.